Mineralized and GSH-responsive hyaluronic acid based nano-carriers for potentiating repressive effects of sulforaphane on breast cancer stem cells-like properties
HF Gu, F Ren, XY Mao, M Du - Carbohydrate Polymers, 2021 - Elsevier
Breast cancer stem cell (BCSC) properties are correlated with the malignancy of tumor cells.
Sulforaphane (SFN), a natural isothiocyanate, has anti-cancer effects. However, SFN is an …
Sulforaphane (SFN), a natural isothiocyanate, has anti-cancer effects. However, SFN is an …
pH-responsive sulfated hyaluronic acid nanoparticles targeting tumor cells and CAFs for the treatment of breast cancer
D Wang, J Wu, C Qi, J Dong, X Ding… - Recent Patents on …, 2023 - ingentaconnect.com
Background: Tumor metastasis is a main cause of death in patients with breast cancer. The
cross-talk between cancer-associated fibroblasts (CAFs) and tumor cells plays an important …
cross-talk between cancer-associated fibroblasts (CAFs) and tumor cells plays an important …
The effect of hyaluronic acid functionalized carbon nanotubes loaded with salinomycin on gastric cancer stem cells
H Yao, Y Zhang, L Sun, Y Liu - Biomaterials, 2014 - Elsevier
Gastric cancer stem cells (CSCs) play a crucial role in the initiation, development, relapse
and metastasis of gastric cancer because they are resistant to a standard chemotherapy and …
and metastasis of gastric cancer because they are resistant to a standard chemotherapy and …
A core/shell stabilized polysaccharide-based nanoparticle with intracellular environment-sensitive drug delivery for breast cancer therapy
Y Wu, X Zhang, H Li, P Deng, H Li, T He… - Journal of Materials …, 2018 - pubs.rsc.org
In this work, we developed a novel core/shell chitosan (Cs)/hyaluronan (HA)-based hybrid
nanoparticle, ie SNX@ Cs-SNX/cHA, with good stability in the bloodstream and intracellular …
nanoparticle, ie SNX@ Cs-SNX/cHA, with good stability in the bloodstream and intracellular …
Hybrid nanoparticles coated with hyaluronic acid lipoid for targeted co-delivery of paclitaxel and curcumin to synergistically eliminate breast cancer stem cells
Z Yang, N Sun, R Cheng, C Zhao, J Liu… - Journal of Materials …, 2017 - pubs.rsc.org
Conventional chemotherapy drugs such as paclitaxel (PTX) can effectively inhibit tumor
growth by killing the majority of the proliferating cancer cells; however, it also results in multi …
growth by killing the majority of the proliferating cancer cells; however, it also results in multi …
Folic acid-poly (N-isopropylacrylamide-maltodextrin) nanohydrogels as novel thermo-/pH-responsive polymer for resveratrol breast cancer targeted therapy
Background The long-term sequelae and serious side effects of conventional breast cancer
chemotherapy due to ubiquitous biodistribution and systemic toxicity remain the main …
chemotherapy due to ubiquitous biodistribution and systemic toxicity remain the main …
ATP/Hyals dually responsive core-shell hyaluronan/chitosan-based drug nanocarrier for potential application in breast cancer therapy
H Li, S Zhuang, Y Yang, F Zhou, J Rong… - International Journal of …, 2021 - Elsevier
The stability of self-assembled drug nanocarriers during blood circulation and the controlled
intracellular drug delivery are two challenges in cancer therapy. In this paper, we …
intracellular drug delivery are two challenges in cancer therapy. In this paper, we …
A pH-sensitive nanotherapeutic system based on a marine sulfated polysaccharide for the treatment of metastatic breast cancer through combining chemotherapy and …
T Zhang, H Liu, Y Li, C Li, G Wan, B Chen, C Li… - Acta Biomaterialia, 2019 - Elsevier
Metastasis and chemotherapy resistance are the leading causes of breast cancer mortality.
Celecoxib (CXB), a selective cyclooxygenase-2 (COX-2) inhibitor, has antiangiogenetic …
Celecoxib (CXB), a selective cyclooxygenase-2 (COX-2) inhibitor, has antiangiogenetic …
A polymeric nanocarrier that eradicates breast cancer stem cells and delivers chemotherapeutic drugs
L Lv, Y Shi, Z Deng, J Xu, Z Ye, J He, G Chen, X Yu… - Biomaterials …, 2023 - Springer
Background Drug nanocarriers can markedly reduce the toxicities and side effects of
encapsulated chemotherapeutic drugs in the clinic. However, these drug nanocarriers have …
encapsulated chemotherapeutic drugs in the clinic. However, these drug nanocarriers have …
Smart chondroitin sulfate micelles for effective targeted delivery of doxorubicin against breast cancer metastasis
Introduction Metastasis is a major challenge in breast cancer therapy. The successful
chemotherapy of breast cancer largely depends on the ability to block the metastatic …
chemotherapy of breast cancer largely depends on the ability to block the metastatic …